Citigroup Inc Alector, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Alector, Inc. stock. As of the latest transaction made, Citigroup Inc holds 60,075 shares of ALEC stock, worth $115,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,075

Previous 32,527 84.69%

Holding current value

$115,344

Previous $147,000 90.48%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.34 - $6.58 $119,558 - $181,265	27,548 Added 84.69%	60,075 $280,000
Q2 2024 Aug 12, 2024	SELL	$4.19 - $6.23 $873,401 - $1.3 Million	-208,449 Reduced 86.5%	32,527 $147,000
Q1 2024 May 10, 2024	BUY	$5.69 - $8.08 $901,478 - $1.28 Million	158,432 Added 191.94%	240,976 $1.45 Million
Q4 2023 Feb 09, 2024	BUY	$3.77 - $8.39 $11,389 - $25,346	3,021 Added 3.8%	82,544 $658,000
Q3 2023 Nov 09, 2023	SELL	$5.2 - $8.77 $2,017 - $3,402	-388 Reduced 0.49%	79,523 $515,000
Q2 2023 Aug 10, 2023	SELL	$5.86 - $7.93 $751,632 - $1.02 Million	-128,265 Reduced 61.61%	79,911 $480,000
Q1 2023 May 11, 2023	BUY	$5.85 - $9.84 $631,800 - $1.06 Million	108,000 Added 107.81%	208,176 $1.29 Million
Q4 2022 Feb 09, 2023	SELL	$6.88 - $9.55 $545,308 - $756,933	-79,260 Reduced 44.17%	100,176 $924,000
Q3 2022 Nov 10, 2022	BUY	$8.19 - $13.2 $201,989 - $325,551	24,663 Added 15.93%	179,436 $1.7 Million
Q2 2022 Aug 10, 2022	BUY	$7.65 - $14.24 $839,862 - $1.56 Million	109,786 Added 244.04%	154,773 $1.57 Million
Q1 2022 May 12, 2022	SELL	$13.02 - $20.78 $1.47 Million - $2.35 Million	-113,232 Reduced 71.57%	44,987 $641,000
Q4 2021 Feb 10, 2022	BUY	$19.35 - $25.54 $1.19 Million - $1.58 Million	61,712 Added 63.95%	158,219 $3.27 Million
Q3 2021 Nov 10, 2021	BUY	$21.65 - $39.49 $2.09 Million - $3.81 Million	96,507 New	96,507 $2.2 Million

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account